MR Spectroscopy
Quantitative MR spectroscopy services for metabolite assessment, protocol harmonisation, and trial delivery.
MR spectroscopy (MRS) provides non-invasive quantification of tissue metabolites, enabling insight into physiology, metabolism, and drug response. These measurements complement quantitative MRI biomarkers by adding biochemical specificity in neurological, oncological, and systemic disease studies.
Bioxydyn supports MRS protocol design and harmonisation across sites and scanners, ensuring reproducible acquisition and consistent spectral quality. We implement robust quality control and analysis workflows to produce auditable, trial-ready outputs.
Our spectroscopy services integrate with DCE-MRI, diffusion MRI, relaxometry, and perfusion assays to provide a multi-modal view of tissue status. From study design to reporting, we deliver transparent analysis that supports confident clinical decisions.